Literature DB >> 8981718

Experimental nonenzymatic glycosylation of vitreous collagens occurs by two pathways.

J S Pulido.   

Abstract

PURPOSE: To study the process of nonenzymatic glycosolation of vitreous collagen in vitro to determine the contributions of the classic Maillard pathway and the oxidative pathway, as well as to evaluate possible inhibitors of both pathways.
METHODS: Bovine vitreous collagen was extracted and then incubated with hexoses in vitro. The amount of advanced glycosylation end (AGE) products was measured by fluorometry under varying conditions in the presence and absence of glycosolation inhibitors. Oxygen consumption studies and electron spin resonance spectroscopy with and without free-radical inhibitors were performed to differentiate oxidative from nonoxidative glycosolation.
RESULTS: Vitreous collagen undergoes nonenzymatic glycosolation in the presence of glucose or galactose in vitro. Oxygen consumption data show that oxygen is consumed in glucose and galactose solutions. Oxygen consumption is decreased by known free-radical inhibitors and rutin but not aminoguanidine. Electron spin resonance spectroscopy demonstrated the presence of a carbon-centered radical, and known free-radical inhibitors decreased the carbon-centered signal.
CONCLUSIONS: Nonenzymatic glycosolation of vitreous collagen can occur not only by the classic nonoxidative pathway, but also by a second oxidative pathway that is susceptible to a number of inhibitors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981718      PMCID: PMC1312117     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  102 in total

Review 1.  The pharmacology of aldose reductase inhibitors.

Authors:  P F Kador; W G Robison; J H Kinoshita
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

2.  A new look at vitreous-humour collagen.

Authors:  S Ayad; J B Weiss
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

3.  Localization of aldose reductase in the human eye.

Authors:  Y Akagi; Y Yajima; P F Kador; T Kuwabara; J H Kinoshita
Journal:  Diabetes       Date:  1984-06       Impact factor: 9.461

4.  Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.

Authors:  A Beyer-Mears; L Ku; M P Cohen
Journal:  Diabetes       Date:  1984-06       Impact factor: 9.461

5.  Pathologic studies of the blood--retinal barrier in the spontaneously diabetic BB rat.

Authors:  N P Blair; M O Tso; J T Dodge
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-03       Impact factor: 4.799

6.  Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.

Authors:  D Finegold; S A Lattimer; S Nolle; M Bernstein; D A Greene
Journal:  Diabetes       Date:  1983-11       Impact factor: 9.461

7.  Experimental galactosemia produces diabetic-like retinopathy.

Authors:  R L Engerman; T S Kern
Journal:  Diabetes       Date:  1984-01       Impact factor: 9.461

8.  Relation between complications of type I diabetes mellitus and collagen-linked fluorescence.

Authors:  V M Monnier; V Vishwanath; K E Frank; C A Elmets; P Dauchot; R R Kohn
Journal:  N Engl J Med       Date:  1986-02-13       Impact factor: 91.245

9.  Nonenzymatic glucosylation of lysyl and hydroxylysyl residues in type I and type II collagens.

Authors:  A J Perejda; E J Zaragoza; E Eriksen; J Uitto
Journal:  Coll Relat Res       Date:  1984-12

10.  Ascorbic acid levels in aqueous and vitreous humors of the rabbit: effects of inflammation and ceruloplasmin.

Authors:  M C McGahan
Journal:  Exp Eye Res       Date:  1985-09       Impact factor: 3.467

View more
  2 in total

1.  Immunogenicity of advanced glycation end products in diabetic patients and in nephropathic non-diabetic patients on hemodialysis or after renal transplantation.

Authors:  A M Buongiorno; S Morelli; E Sagratella; R Cipriani; S Mazzaferro; S Morano; M Sensi
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

Review 2.  A role for excitatory amino acids in diabetic eye disease.

Authors:  Jose E Pulido; Jose S Pulido; Jay C Erie; Jorge Arroyo; Kurt Bertram; Miao-Jen Lu; Scott A Shippy
Journal:  Exp Diabetes Res       Date:  2007
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.